Ovarian Cancer: Charlotte
SurvivorNet has collaborated with patients and physicians to provide women in Charlotte, North Carolina with helpful information and support during their ovarian cancer journey. We hope these resources make it easier to connect with people in your neighborhood who can help.
Learning to Embrace it - Charlotte Survivor Diana Faison's Story
"The gift that cancer gives you is the friends, family, and faith like you've never experienced," says Charlotte ovarian cancer survivor Diana Faison. The day before her 58th birthday, Faison underwent a hysterectomy [the removal of a woman's uterus] during her battle with ovarian cancer. She knew that she would even... Read More
- For many women, surgery is the first treatment for ovarian cancer
- The procedure is typically done through an incision in the abdomen
- Less than 3% of patients experience severe complications
Ovarian Cancer Surgery: A Guide from Charlotte's Experts
- For many women, surgery is the first treatment for ovarian cancer
- The procedure is typically done through an incision in the abdomen
- Less than 3% of patients experience severe complications
- Chemotherapy for ovarian cancer usually involves two drugs - carboplatin and paclitaxel
- Typically, six treatments are given – one every three weeks
- The chemo infusion usually lasts around six hours
Understanding Chemotherapy for Ovarian Cancer
- Chemotherapy for ovarian cancer usually involves two drugs -Â carboplatin and paclitaxel
- Typically, six treatments are given – one every three weeks
- The chemo infusion usually lasts around six hours
In the midst of the COVID-19 pandemic, it's understandable that ovarian cancer patients are especially concerned about their health and their ongoing access to treatment. Many elective procedures are being postponed around the country, and patients may be worried about upcoming surgery or ongoing chemotherapy and oth... Read More
- PARP inhibitors help extend life by keeping ovarian cancer cells from repairing and replicating
- This class of drugs is now potentially an option for almost all women with ovarian cancer
- Women with a BRCA genetic mutation get more benefit from PARP Inhibitors
- New research finds women without a BRCA mutation can still benefit
PARP Inhibitors Provide New Options
- PARP inhibitors help extend life by keeping ovarian cancer cells from repairing and replicating
- This class of drugs is now potentially an option for almost all women with ovarian cancer
- Women with a BRCA genetic mutation get more benefit from PARP Inhibitors
- New research finds women without a BRCA mutation can still benefit
Considering Palliative Care
"Palliative care is an area of medicine that focuses on supporting quality of life," says Dr. Janelle Fauci, a gynecologic oncologist at Novant Health in Charlotte, NC. "It's not so much treatment-focused or duration of life focused." Palliative care is an important step in ovarian cancer treatment, as it focuses on tr... Read More
